502 related articles for article (PubMed ID: 34123820)
1. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
3. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
4. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
5. Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma.
Cui Y; Zhang S; Miao C; Liang C; Chen X; Yan T; Bu H; Dong H; Li J; Li J; Wang Z; Liu B
Transl Androl Urol; 2021 Aug; 10(8):3317-3331. PubMed ID: 34532256
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma.
Feng R; Li H; Meng T; Fei M; Yang C
Discov Oncol; 2024 May; 15(1):187. PubMed ID: 38797784
[TBL] [Abstract][Full Text] [Related]
7. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
8. The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Deng L; Wang P; Qu Z; Liu N
Front Genet; 2021; 12():667610. PubMed ID: 34567057
[No Abstract] [Full Text] [Related]
9. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
10. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
11. Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma.
Xu T; Liu Y; Ning B; Luo M; Wei Y
Transl Androl Urol; 2024 Apr; 13(4):509-525. PubMed ID: 38721281
[TBL] [Abstract][Full Text] [Related]
12. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
13. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
14. Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma.
Zhang D; Zeng S; Hu X
Cancer Cell Int; 2020; 20():319. PubMed ID: 32694941
[TBL] [Abstract][Full Text] [Related]
15. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
17. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
Zhang P; Liu G; Lu L
Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
[TBL] [Abstract][Full Text] [Related]
18. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
Weng C; Wang L; Liu G; Guan M; Lu L
Front Oncol; 2021; 11():763027. PubMed ID: 34868980
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma.
Sun Z; Jing C; Xiao C; Li T
Front Oncol; 2020; 10():1430. PubMed ID: 32974157
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network.
Gong K; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
PLoS One; 2021; 16(6):e0252452. PubMed ID: 34101736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]